|
⚲
|
| Keyboard |
| Clare Ozawa | |
|---|---|
| Firm | |
| Address | c/o 858 Therapeutics, Inc 3115 Merryfield Row, Suite 110 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lycia Therapeutics Inc | 021-588627 | Director | 75.0 M of 75.0 M |
||
| 858 Therapeutics Inc | 021-518431 | Director | 25.2 M of 50.4 M |
||
| Lycia Therapeutics Inc | 021-514102 | Director | 106.6 M of 106.6 M |
||
| Versant Venture Capital SPV I SAB LP | 021-512829 | Executive Officer | 5.0 M of 5.0 M |
||
| Lenz Therapeutics Inc | 021-475519 | Director | 83.5 M of 83.5 M |
||
| March Therapeutics Inc | 021-459743 | Director | 20.3 M of 30.3 M |
||
| Lycia Therapeutics Inc | 021-413559 | Director | 70.1 M of 70.1 M |
||
| 858 Therapeutics Inc | 021-399747 | Director | 20.0 M of 40.0 M |
||
| Lenz Therapeutics Inc | 021-380075 | Director | 49.0 M of 49.0 M |
||
| Jengu Therapeutics Inc | 021-376272 | Director | 5.0 M of 50.0 M |
||
| Lycia Therapeutics Inc | 021-363038 | Director | 25.4 M of 50.4 M |
||
| 858 Therapeutics Inc | 021-362558 | Director | 20.1 M of 37.5 M |
||
| Oyster Point Pharma Inc | 021-333703 | Director | 85.0 M of 93.0 M |
||
| Mistral Therapeutics Inc | 021-315373 | Director | 25.9 M of 59.3 M |
||
| Inception IBD Inc | 021-253915 | Executive Officer | 6.9 M of 19.1 M |
||
| Versant Venture Management LLC | |||||
| Versant Vantage III LP | 021-461398 | Executive Officer | 298.7 M of 298.7 M |
295.6 M | |
| Versant Venture Capital IX LP | 021-461417 | Executive Officer | 600.4 M of 600.4 M |
586.2 M | |
| Versant Voyageurs III LP | 021-461406 | Executive Officer | 300.2 M of 300.2 M |
311.8 M | |
| Versant Vantage II LP | 021-380952 | Executive Officer | 253.9 M of 253.9 M |
249.7 M | |
| Versant Venture Capital VIII LP | 021-380948 | Executive Officer | 560.2 M of 560.2 M |
886.9 M | |
| Versant Voyageurs II LP | 021-380951 | Executive Officer | 140.1 M of 140.1 M |
169.0 M | |
| Versant Vantage I LP | 021-334361 | Director | of 150.0 M |
69.9 M | |
| Versant Venture Capital VII LP | 021-321509 | Director | 600.0 M of 600.0 M |
676.7 M | |
| Related People Network |
|---|
| Network #136 at Versant Venture Management LLC — files alongside 27 co-filers |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Tender | 2,236,888 | ||
|
Oyster Point Pharma Inc OYST
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Disposed to issuer | 5,199 | ||
|
Oyster Point Pharma Inc OYST
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Disposed to issuer | 5,359 | ||
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Tender | 414,607 | ||
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Tender | 1,003,658 | ||
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Tender | 2,465 | ||
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Disposed to issuer | 11,064 | ||
|
Oyster Point Pharma Inc OYST
Common Stock
|
2023-01-03 | Disposed to issuer | 3,573 | ||
|
Oyster Point Pharma Inc OYST
Stock Option (Right to Buy) · derivative
|
2022-06-06 | Grant | 5,359 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-06-06 | Grant | 3,573 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-01-05 | Other | 51,556 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-01-05 | Other | 1,261 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-01-05 | Other | 200,213 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-01-05 | Other | 51,556 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2022-01-05 | Other | 120 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2021-12-21 | Other | 51,556 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2021-12-21 | Other | 1,261 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2021-12-21 | Other | 200,213 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2021-12-21 | Other | 51,556 | $0.00 | |
|
Oyster Point Pharma Inc OYST
Common Stock
|
2021-12-21 | Other | 120 | $0.00 | |
| showing 20 of 51 most recent transactions | |||||